Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center (Q37380454)

From Wikidata
Jump to navigation Jump to search
scientific article published on 17 August 2015
edit
Language Label Description Also known as
English
Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center
scientific article published on 17 August 2015

    Statements

    Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center (English)
    Nelly G Adel
    Thu-Oanh Dang
    Michael A Postow
    Margaret K Callahan
    Richard D Carvajal
    Mark A Dickson
    Kaitlin M Woo
    Paul B Chapman
    17 August 2015
    3193-3198

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit